| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
The Oncology Institute, Inc.
13D/A
STLN · 68236X100
|
4.7% |
4/23/2025
Event 3/26/2025
|
||||
| Ravi Sarin | 4.7% | |||||
| OncologyCare Partners, LLC | 4.7% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.